The findings challenge long-standing assumptions about therapy-related cancers. They also highlight how drug actions can substitute for genetic changes in tumor development. An international team of researchers, including Prof. Kirsten Kübler from the Berlin Institute of Health at Charité (BIH) and collaborators at the Broad Institute of MIT and Harvard, Mass General Brigham, and the [...]from SciTechDaily https://ift.tt/3mA4wRj
